The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.
about
The Influence of Neurocognitive Impairment on HIV Risk Behaviors and Intervention Outcomes among High-Risk Substance Users: A Systematic ReviewExamining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru.Sex-Related Differences in Self-Reported Neurocognitive Impairment among High-Risk Cocaine Users in Methadone Maintenance Treatment ProgramAn Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru.Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in TreatmentWillingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment.Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.Problematic alcohol use among individuals with HIV: relations with everyday memory functioning and HIV symptom severity.A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.
P2860
Q26767216-612726AE-CCE0-4158-99A7-BD2300115788Q33452059-B536078F-F36A-42FB-8366-6353E6DEA628Q33658647-83DD74ED-8D10-4741-A74A-92B9CF6F0C9DQ34458805-FDA377EF-ABB9-4AED-9313-EE7DBC5269BBQ35186085-A753FFC3-563C-4BB9-B5C7-6BF402ABE0F3Q36642769-0EAD38CF-85C2-42DA-906E-2F708463B288Q38690141-32056E08-AA6F-41A5-A92A-D913B6DD0910Q38884773-6ABBC1E5-D4B8-4F3A-8F71-8B1314040221Q40404705-49AC4B12-8DA4-470D-8556-5B4513633633Q40492630-9C6BD705-DD41-4104-B9D4-D564D2B7A34DQ41697741-94EB54CE-E4FA-40D8-A393-0A11B6C3477FQ44609297-23E1A106-B2D2-42C8-B83D-78C036BCC2D6Q50099929-1E8FB530-BD92-4D0F-AEF6-AB4B23EE49A5
P2860
The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@ast
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@en
type
label
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@ast
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@en
prefLabel
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@ast
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@en
P2093
P2860
P1433
P1476
The influence of neurocognitiv ...... d people living with HIV/AIDS.
@en
P2093
Ifeoma Ezeabogu
Jessica Potrepka
Michael M Copenhaver
P2860
P304
P356
10.1080/09540121.2011.608794
P577
2012-01-17T00:00:00Z